United Blood Services provides therapeutic apheresis services at selected blood center locations or, by arrangement, at the hospital for the convenience and safety of the patient.
The theoretical basis for therapeutic apheresis is to reduce the patient’s load of a pathologic substance to levels that will allow clinical improvement. The term “therapeutic apheresis” is used for the general procedure and the term “therapeutic plasma exchange” (TPE) is used for procedures in which the goal is to remove plasma containing the pathologic substance and replace it with normal plasma or a starch- or albumin-based crystalloid or colloid solution.
Types and Indications
Plasmapheresis – Therapeutic plasma exchange is indicated for several hematologic and neurologic conditions. Conditions such as Serum Hyperviscosity Syndrome, Thrombotic Thrombocytopenic Purpura/Hemolytic-Uremic Syndrome (TTP/HUS), Myasthenia Gravis and Acute Guillain-Barre Syndrome have been treated with TPE procedures.
Leukapheresis – Therapeutic white cell depletion has been used to treat dramatically elevated white cell counts that can occur in acute leukemia.
Erythrocytapheresis – Therapeutic red cell removal and exchange may be used to treat complications of Sickle Cell Disease.
Plateletpheresis – Platelet depletion can be used for Thrombocythemia in symptomatic patients with platelet counts above 1,000,000/uL.
United Blood Services’ mobile therapeutic apheresis program offers the following benefits:
The patient’s physician:
The physician’s office/hospital:
United Blood Services:
Contact your United Blood Services center to find out more about options for therapeutic apheresis. To find the center nearest you click here.